A carregar...
Preclinical development of CD126 CAR-T cells with broad antitumor activity
Chimeric antigen receptor T (CAR-T) cell therapy is a transformative approach to cancer eradication. CAR-T is expensive partly due to the restricted use of each CAR construct for specific tumors. Thus, a CAR construct with broad antitumor activity can be advantageous. We identified that CD126 is exp...
Na minha lista:
| Publicado no: | Blood Cancer J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7791061/ https://ncbi.nlm.nih.gov/pubmed/33414408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-020-00405-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|